DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Brandes AA, Franceschi E, Tosoni A. et al.
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
J Clin Oncol 2008;
26 (13) 2192-2197
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.